Clinical Trial Update: Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating neo-adjuvant glioma lysate vaccines in WHO Grade II glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Grade Ii
• Glioma
• Malignant Glioma
• Oligoastrocytoma
• Oligodendroglioma

Drugs mentioned

• Glioma Lysate Vaccine (glioma lysate vaccine)

Snippet

Sponsor: Jennie Taylor | Conditions: Oligodendroglioma, Astrocytoma, Grade II | Phase 1 | Status: COMPLETED